
Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition
Keywords: Prostate cancer; Bone metastases; Zoledronic acid; RANK; RANKL; DenosumabCáncer de próstata; Metástasis óseas; Acido zoledrónico; RANK; RANKL; Denosumab